I thought the statement that the phase II trials in both the US and Russia were ongoing was important since the US trial was PRd to have started the first week in February. Assuming it started in the US on Friday the 5th of February, it has been ongoing for 17 days meaning that if a patient was recruited and started on B that day, they have only 12 days to go until the 29th day (trial end date). The "developments" referred to in the late notice last week have not been provided as well. I would think if Leo received positive news (developments) about the trial, he would be extremely cautious about sharing anything until he has all of the information and is certain about what the data indicates. This is way too important of a situation to be jumping the gun and disclosing preliminary information.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links